Daily versus alternate day oral iron supplementation for the treatment of iron deficiency anaemia in pregnancy (IronMother)

niversity College Dublin0 个研究点目标入组 230 人开始时间: 2024年4月16日最近更新: 2024年7月22日

适应症

试验速览

暂无简介。

•Subjects must be able and willing to give written informed consent and to comply with the requirements of this study protocol, Subjects must be aged 18 years or above at baseline, Subjects will need to have a standard of English good enough to understand and read the information leaflet and consent form and communicate easily with the research team, A diagnosis of IDA as defined by Hb <10.5g/dL but not =7g/dl and a serum ferritin of <30µg/L, Singleton pregnancies, Gestational age of 14- 34 weeks’ gestation, A level of English high enough for informed consent and study participation

•Women <18 years of age, Allergy/sensitivity to Galfer or their ingredients, Subjects unable to provide written informed consent or who require an interpreter, Presence of an underlying haemoglobinopathy, Severe anaemia as defined by Hb =7g/dl, Subjects who have any other significant disease or disorder (including inflammatory bowel disease, haemochromatosis, haemoglobinopathy, any active inflammatory diseases, malabsorptive conditions) which, in the opinion of the investigator, may either put the subject at risk by participation in the study, or may influence the result of the study., Any underlying medical disorder or medications that the research team feel would impact iron absorption eg. Hyperemesis, Coeliac’s disease, inflammatory bowel disease, anaemia of chronic disease or anaemia related to other causes (B12/Folate), previous bariatric surgery, active PUD, haemochromatosis, Multiple pregnancy, Not taking medications in a way which could potentially hinder the absorption of iron eg. PPIs, Antacids, levothyroxine all need to be taken separately to iron

发起方

niversity College Dublin